Tendon sheath disorder
diseaseOn this page
Also known as disease of tendon sheathdisease or disorder of tendon sheathdisorder of tendon sheathtendon sheath diseasetendon sheath disease or disorder
Summary
Tendon sheath disorder (MONDO:0024876) is a disease with 1 GWAS associations across 2 studies. A subtype of disease of the tendon — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- GWAS associations: 1
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | tendon sheath disorder |
| Mondo ID | MONDO:0024876 |
| SNOMED CT | 312381009 |
| UMLS | C0729734 |
| MedGen | 675994 |
| Anatomy (UBERON) | UBERON:0000304 |
| Is cancer (heuristic) | no |
Also known as: disease of tendon sheath · disease or disorder of tendon sheath · disorder of tendon sheath · tendon sheath disease · tendon sheath disease or disorder · tendon sheath disorder
Data availability: 1 GWAS association (2 studies).
Disease family
This is a subtype of disease of the tendon. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by body system or component › musculoskeletal system disorder › disease of the tendon › tendon sheath disorder
Related subtypes (2): tendinitis, tendinosis
Subtypes (4): tenosynovial giant cell tumor, tendon sheath lipoma, tenosynovitis, tendon sheath fibroma
Genetics & variants
GWAS landscape
1 GWAS associations across 2 studies. Top hits map to 1 distinct genes (as reported by GWAS).
Top associations by p-value
| rsID | p-value | Gene | Risk allele | Odds ratio |
|---|---|---|---|---|
| rs151042767 | 5e-09 | CPSF6 | ? |
Top studies (by case count)
| Study | Lead author | Year | Cases | Controls | Title |
|---|---|---|---|---|---|
| GCST90651388 | Liu TY | 2025 | 119 | 210,582 | Diversity and longitudinal records: Genetic architecture of disease associations and polygenic risk in the Taiwanese Han population. |
| GCST90044566 | Jiang L | 2021 | 102 | 456,246 | A generalized linear mixed model association tool for biobank-scale data. |
Variant details and genetic-evidence tiers
Tier distribution (top 50 variants)
| Tier | Variants |
|---|---|
| Tier 1: coding | 0 |
| Tier 2: splice/UTR | 0 |
| Tier 3: regulatory | 0 |
| Tier 4: intronic/intergenic | 1 |
MAF distribution
| Bucket | Variants |
|---|---|
| common (>=0.05) | 0 |
| low_freq (0.01-0.05) | 0 |
| rare (<0.01) | 0 |
| unknown | 1 |
Functional consequences
| Consequence | Count |
|---|---|
| intron_variant | 1 |
Top variants
| rsID | Chr | Pos | Alleles | MAF | Consequence | Gene | p-value | Tier |
|---|---|---|---|---|---|---|---|---|
| rs151042767 | 12 | 69248035 | C>T | intron_variant | CPSF6 | 5e-09 | Tier 4: intronic/intergenic |
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.